H.R. 1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

H.R. 1843 is a federal bill in the 119th Congress. Currently, generic drug manufacturers submit applications to the FDA without a clear understanding of whether their proposed drug is considered chemically identical to an existing brand-name drug. This bill changes that by requiring the FDA, upon request… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.